Host CYP27A1 expression is essential for ovarian cancer progression

Sisi He, Liqian Ma, Amy E. Baek, Anna Vardanyan, Varsha Vembar, Joy J. Chen, Adam T. Nelson, Joanna E. Burdette, Erik Nelson

Research output: Contribution to journalArticle

Abstract

There is an urgent need for more effective strategies to treat ovarian cancer. Elevated cholesterol levels are associated with a decreased progression-free survival time (PFS) while statins are protective. 27-Hydroxycholesterol (27HC), a primary metabolite of cholesterol, has been shown to modulate the activities of the estrogen receptors (ERs) and liver x receptors (LXRs) providing a potential mechanistic link between cholesterol and ovarian cancer progression. We found that high expression of CYP27A1, the enzyme responsible for the synthesis of 27HC, was associated with decreased PFS, while high expression of CYP7B1, responsible for 27HC catabolism, was associated with increased PFS. However, 27HC decreased the cellular proliferation of various ovarian cancer cell lines in an LXR-dependent manner. Intriguingly, ID8 grafts were unable to effectively establish in CYP27A1−/− mice, indicating involvement of the host environment. Tumors from mice treated with 27HC had altered myeloid cell composition, and cells from the marrow stem cell lineage were found to be responsible for the effects in CYP27A1−/− mice. While inhibition of CYP27A1 or immune checkpoint did not significantly alter tumor size, their combination did, thereby highlighting this axis as a therapeutic target.

Original languageEnglish (US)
Pages (from-to)659-675
Number of pages17
JournalEndocrine-Related Cancer
Volume26
Issue number7
DOIs
StatePublished - Jan 1 2019

Fingerprint

Ovarian Neoplasms
Disease-Free Survival
Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Liver
Cell Lineage
Myeloid Cells
Hypercholesterolemia
Estrogen Receptors
Neoplasms
Stem Cells
Bone Marrow
Cell Proliferation
27-hydroxycholesterol
Transplants
Cell Line
Enzymes
Therapeutics

Keywords

  • 27-hydroxycholesterol
  • Cholesterol
  • Myeloid-derived suppressor cells
  • Ovarian cancer
  • Tumor microenvironment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Cancer Research

Cite this

He, S., Ma, L., Baek, A. E., Vardanyan, A., Vembar, V., Chen, J. J., ... Nelson, E. (2019). Host CYP27A1 expression is essential for ovarian cancer progression. Endocrine-Related Cancer, 26(7), 659-675. https://doi.org/10.1530/ERC-18-0572

Host CYP27A1 expression is essential for ovarian cancer progression. / He, Sisi; Ma, Liqian; Baek, Amy E.; Vardanyan, Anna; Vembar, Varsha; Chen, Joy J.; Nelson, Adam T.; Burdette, Joanna E.; Nelson, Erik.

In: Endocrine-Related Cancer, Vol. 26, No. 7, 01.01.2019, p. 659-675.

Research output: Contribution to journalArticle

He, S, Ma, L, Baek, AE, Vardanyan, A, Vembar, V, Chen, JJ, Nelson, AT, Burdette, JE & Nelson, E 2019, 'Host CYP27A1 expression is essential for ovarian cancer progression', Endocrine-Related Cancer, vol. 26, no. 7, pp. 659-675. https://doi.org/10.1530/ERC-18-0572
He S, Ma L, Baek AE, Vardanyan A, Vembar V, Chen JJ et al. Host CYP27A1 expression is essential for ovarian cancer progression. Endocrine-Related Cancer. 2019 Jan 1;26(7):659-675. https://doi.org/10.1530/ERC-18-0572
He, Sisi ; Ma, Liqian ; Baek, Amy E. ; Vardanyan, Anna ; Vembar, Varsha ; Chen, Joy J. ; Nelson, Adam T. ; Burdette, Joanna E. ; Nelson, Erik. / Host CYP27A1 expression is essential for ovarian cancer progression. In: Endocrine-Related Cancer. 2019 ; Vol. 26, No. 7. pp. 659-675.
@article{b778970a4769425598cdd74d30e593de,
title = "Host CYP27A1 expression is essential for ovarian cancer progression",
abstract = "There is an urgent need for more effective strategies to treat ovarian cancer. Elevated cholesterol levels are associated with a decreased progression-free survival time (PFS) while statins are protective. 27-Hydroxycholesterol (27HC), a primary metabolite of cholesterol, has been shown to modulate the activities of the estrogen receptors (ERs) and liver x receptors (LXRs) providing a potential mechanistic link between cholesterol and ovarian cancer progression. We found that high expression of CYP27A1, the enzyme responsible for the synthesis of 27HC, was associated with decreased PFS, while high expression of CYP7B1, responsible for 27HC catabolism, was associated with increased PFS. However, 27HC decreased the cellular proliferation of various ovarian cancer cell lines in an LXR-dependent manner. Intriguingly, ID8 grafts were unable to effectively establish in CYP27A1−/− mice, indicating involvement of the host environment. Tumors from mice treated with 27HC had altered myeloid cell composition, and cells from the marrow stem cell lineage were found to be responsible for the effects in CYP27A1−/− mice. While inhibition of CYP27A1 or immune checkpoint did not significantly alter tumor size, their combination did, thereby highlighting this axis as a therapeutic target.",
keywords = "27-hydroxycholesterol, Cholesterol, Myeloid-derived suppressor cells, Ovarian cancer, Tumor microenvironment",
author = "Sisi He and Liqian Ma and Baek, {Amy E.} and Anna Vardanyan and Varsha Vembar and Chen, {Joy J.} and Nelson, {Adam T.} and Burdette, {Joanna E.} and Erik Nelson",
year = "2019",
month = "1",
day = "1",
doi = "10.1530/ERC-18-0572",
language = "English (US)",
volume = "26",
pages = "659--675",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "7",

}

TY - JOUR

T1 - Host CYP27A1 expression is essential for ovarian cancer progression

AU - He, Sisi

AU - Ma, Liqian

AU - Baek, Amy E.

AU - Vardanyan, Anna

AU - Vembar, Varsha

AU - Chen, Joy J.

AU - Nelson, Adam T.

AU - Burdette, Joanna E.

AU - Nelson, Erik

PY - 2019/1/1

Y1 - 2019/1/1

N2 - There is an urgent need for more effective strategies to treat ovarian cancer. Elevated cholesterol levels are associated with a decreased progression-free survival time (PFS) while statins are protective. 27-Hydroxycholesterol (27HC), a primary metabolite of cholesterol, has been shown to modulate the activities of the estrogen receptors (ERs) and liver x receptors (LXRs) providing a potential mechanistic link between cholesterol and ovarian cancer progression. We found that high expression of CYP27A1, the enzyme responsible for the synthesis of 27HC, was associated with decreased PFS, while high expression of CYP7B1, responsible for 27HC catabolism, was associated with increased PFS. However, 27HC decreased the cellular proliferation of various ovarian cancer cell lines in an LXR-dependent manner. Intriguingly, ID8 grafts were unable to effectively establish in CYP27A1−/− mice, indicating involvement of the host environment. Tumors from mice treated with 27HC had altered myeloid cell composition, and cells from the marrow stem cell lineage were found to be responsible for the effects in CYP27A1−/− mice. While inhibition of CYP27A1 or immune checkpoint did not significantly alter tumor size, their combination did, thereby highlighting this axis as a therapeutic target.

AB - There is an urgent need for more effective strategies to treat ovarian cancer. Elevated cholesterol levels are associated with a decreased progression-free survival time (PFS) while statins are protective. 27-Hydroxycholesterol (27HC), a primary metabolite of cholesterol, has been shown to modulate the activities of the estrogen receptors (ERs) and liver x receptors (LXRs) providing a potential mechanistic link between cholesterol and ovarian cancer progression. We found that high expression of CYP27A1, the enzyme responsible for the synthesis of 27HC, was associated with decreased PFS, while high expression of CYP7B1, responsible for 27HC catabolism, was associated with increased PFS. However, 27HC decreased the cellular proliferation of various ovarian cancer cell lines in an LXR-dependent manner. Intriguingly, ID8 grafts were unable to effectively establish in CYP27A1−/− mice, indicating involvement of the host environment. Tumors from mice treated with 27HC had altered myeloid cell composition, and cells from the marrow stem cell lineage were found to be responsible for the effects in CYP27A1−/− mice. While inhibition of CYP27A1 or immune checkpoint did not significantly alter tumor size, their combination did, thereby highlighting this axis as a therapeutic target.

KW - 27-hydroxycholesterol

KW - Cholesterol

KW - Myeloid-derived suppressor cells

KW - Ovarian cancer

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85068823285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068823285&partnerID=8YFLogxK

U2 - 10.1530/ERC-18-0572

DO - 10.1530/ERC-18-0572

M3 - Article

C2 - 31048561

AN - SCOPUS:85068823285

VL - 26

SP - 659

EP - 675

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 7

ER -